SCHEMBL1999482

SCHEMBL1999482

O=C1CN(Cc2ccc(-c3cccc(CN4CCS(=O)(=O)CC4)c3)cc2)C(=O)N1C1CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 3/20 0.48
LMNA P02545 1/20 0.42
DHODH Q02127 1/20 0.42
FAAH O00519 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
JAK1 P23458 4/20 0.39
JAK2 O60674 2/20 0.39
TYK2 P29597 2/20 0.39
KCNH2 Q12809 2/20 0.39
CYP2C19 P33261 2/20 0.39
STK10 O94804 1/20 0.39
ABL1 P00519 1/20 0.39
CYP1A2 P05177 1/20 0.39
CSF1R P07333 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
FLT3 P36888 1/20 0.39
STAT1 P42224 1/20 0.39
IRAK1 P51617 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2000525 0.96 ENPP2 (0.52) ENPP2LMNADHODHFAAHMEN1
SCHEMBL1997408 0.87 ENPP2 (0.49) ENPP2MEN1KMT2ACYP2C19HRH3
SCHEMBL1998115 0.84 LMNA (0.41) ENPP2LMNADHODHFAAHMEN1
SCHEMBL2002675 0.82 DHODH (0.43) ENPP2LMNADHODHFAAHMEN1
SCHEMBL1998199 0.81 ENPP2 (0.50) ENPP2MEN1KMT2AJAK1JAK2
SCHEMBL839140 0.78 ENPP2 (0.47) ENPP2LMNAMEN1KMT2AJAK1
SCHEMBL838691 0.76 ENPP2 (0.43) ENPP2DHODHMEN1KMT2AJAK1
SCHEMBL839915 0.73 ENPP2 (0.46) ENPP2DHODHMEN1KMT2AJAK1
SCHEMBL1998174 0.72 CYP2D6 (0.48) ENPP2CYP2C19HRH3MCHR1CYP2D6
SCHEMBL1998349 0.71 ENPP2 (0.48) ENPP2JAK2KCNH2CYP2C19HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US claimed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US claimed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 ENPP2 1556/4885LMNA 4840/4885DHODH 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.